Cargando…

A Luminacin D Analog HL142 Inhibits Ovarian Tumor Growth and Metastasis by Reversing EMT and Attenuating the TGFβ and FAK Pathways

Epithelial to mesenchymal transition (EMT) is known to contribute to tumor metastasis and chemoresistance. Reversing EMT using small molecule inhibitors to target EMT associated gene expression represents an effective strategy for cancer treatment. The purpose of this study is to test whether a new...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Baojin, Li, Hanxuan, Zhao, Xinxin, Zhang, Wenjing, Zhao, Guannan, Wu, Zhongzhi, Zhang, Ruitao, Dong, Peixin, Watari, Hidemichi, Tigyi, Gabor, Li, Wei, Yue, Junming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364639/ https://www.ncbi.nlm.nih.gov/pubmed/34405025 http://dx.doi.org/10.7150/jca.61066

Ejemplares similares

Cryptotanshinone inhibits ovarian tumor growth and metastasis by degrading c-Myc and attenuating the FAK signaling pathway
por: Guo, Huijun, et al.
Publicado: (2022)

EIF5A2 controls ovarian tumor growth and metastasis by promoting epithelial to mesenchymal transition via the TGFβ pathway
por: Zhao, Guannan, et al.
Publicado: (2021)

FAK PROTAC Inhibits Ovarian Tumor Growth and Metastasis by Disrupting Kinase Dependent and Independent Pathways
por: Huo, Xueyun, et al.
Publicado: (2022)

Integrated multi-omics analyses and functional validation reveal TTK as a novel EMT activator for endometrial cancer
por: Miao, Yu, et al.
Publicado: (2023)

miR-203 inhibits ovarian tumor metastasis by targeting BIRC5 and attenuating the TGFβ pathway
por: Wang, Baojin, et al.
Publicado: (2018)

Long non-coding RNA DLEU2 drives EMT and glycolysis in endometrial cancer through HK2 by competitively binding with miR-455 and by modulating the EZH2/miR-181a pathway
por: Dong, Peixin, et al.
Publicado: (2021)

MicroRNA-361-Mediated Inhibition of HSP90 Expression and EMT in Cervical Cancer Is Counteracted by Oncogenic lncRNA NEAT1
por: Xu, Daozhi, et al.
Publicado: (2020)

Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4–miR-18a pathway in cervical cancer
por: Dong, Peixin, et al.
Publicado: (2018)

Correction: Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4–miR-18a pathway in cervical cancer
por: Dong, Peixin, et al.
Publicado: (2019)

Lentiviral CRISPR/Cas9 nickase vector mediated BIRC5 editing inhibits epithelial to mesenchymal transition in ovarian cancer cells
por: Zhao, Guannan, et al.
Publicado: (2017)

iASPP induces EMT and cisplatin resistance in human cervical cancer through miR-20a-FBXL5/BTG3 signaling
por: Xiong, Ying, et al.
Publicado: (2017)

MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells
por: Dong, Peixin, et al.
Publicado: (2016)

Knockout of MTF1 Inhibits the Epithelial to Mesenchymal Transition in Ovarian Cancer Cells
por: Ji, Liang, et al.
Publicado: (2018)

Musashi-2, a novel oncoprotein promoting cervical cancer cell growth and invasion, is negatively regulated by p53-induced miR-143 and miR-107 activation
por: Dong, Peixin, et al.
Publicado: (2017)

B7H3 As a Promoter of Metastasis and Promising Therapeutic Target
por: Dong, Peixin, et al.
Publicado: (2018)

miR-34a, miR-424 and miR-513 inhibit MMSET expression to repress endometrial cancer cell invasion and sphere formation
por: Dong, Peixin, et al.
Publicado: (2018)

Tumor-Intrinsic PD-L1 Signaling in Cancer Initiation, Development and Treatment: Beyond Immune Evasion
por: Dong, Peixin, et al.
Publicado: (2018)

The Expression, Functions and Mechanisms of Circular RNAs in Gynecological Cancers
por: Dong, Peixin, et al.
Publicado: (2020)

Lentiviral CRISPR/Cas9 vector mediated miR-21 gene editing inhibits the epithelial to mesenchymal transition in ovarian cancer cells
por: Huo, Wenying, et al.
Publicado: (2017)

Adipose-Derived Stem Cells Facilitate Ovarian Tumor Growth and Metastasis by Promoting Epithelial to Mesenchymal Transition Through Activating the TGF-β Pathway
por: Liu, Xiaowu, et al.
Publicado: (2021)

Anti-cancer Effect of Luminacin, a Marine Microbial Extract, in Head and Neck Squamous Cell Carcinoma Progression via Autophagic Cell Death
por: Shin, Yoo Seob, et al.
Publicado: (2016)

Exploring lncRNA-Mediated Regulatory Networks in Endometrial Cancer Cells and the Tumor Microenvironment: Advances and Challenges
por: Dong, Peixin, et al.
Publicado: (2019)

Long Non-coding RNA NEAT1: A Novel Target for Diagnosis and Therapy in Human Tumors
por: Dong, Peixin, et al.
Publicado: (2018)

PD-L1 Is a Tumor Suppressor in Aggressive Endometrial Cancer Cells and Its Expression Is Regulated by miR-216a and lncRNA MEG3
por: Xu, Daozhi, et al.
Publicado: (2020)

Critical Roles of PIWIL1 in Human Tumors: Expression, Functions, Mechanisms, and Potential Clinical Implications
por: Dong, Peixin, et al.
Publicado: (2021)

Correlation between FAK and EGF-Induced EMT in Colorectal Cancer Cells
por: Huang, Kun, et al.
Publicado: (2020)

MicroRNA-361: A Multifaceted Player Regulating Tumor Aggressiveness and Tumor Microenvironment Formation
por: Xu, Daozhi, et al.
Publicado: (2019)

Long noncoding RNA NEAT1 drives aggressive endometrial cancer progression via miR-361-regulated networks involving STAT3 and tumor microenvironment-related genes
por: Dong, Peixin, et al.
Publicado: (2019)

Long Non-Coding RNA TMPO-AS1 Promotes GLUT1-Mediated Glycolysis and Paclitaxel Resistance in Endometrial Cancer Cells by Interacting With miR-140 and miR-143
por: Dong, Peixin, et al.
Publicado: (2022)

The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer
por: Dong, Peixin, et al.
Publicado: (2014)

Emerging Therapeutic Biomarkers in Endometrial Cancer
por: Dong, Peixin, et al.
Publicado: (2013)

Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression
por: Dong, Peixin, et al.
Publicado: (2016)

MiRNA-128 and MiRNA-142 Regulate Tumorigenesis and EMT in Oral Squamous Cell Carcinoma Through HOXA10
por: Yao, Yao, et al.
Publicado: (2020)

Suppression of iASPP-dependent aggressiveness in cervical cancer through reversal of methylation silencing of microRNA-124
por: Dong, Peixin, et al.
Publicado: (2016)

Overcoming EMT-associated resistance to anti-cancer drugs via Src/FAK pathway inhibition
por: Wilson, Catherine, et al.
Publicado: (2014)

Calretinin promotes invasiveness and EMT in malignant mesothelioma cells involving the activation of the FAK signaling pathway
por: Wörthmüller, Janine, et al.
Publicado: (2018)

MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1
por: Dong, Peixin, et al.
Publicado: (2011)

Downregulation of microRNA-4324 promotes the EMT of esophageal squamous-cell carcinoma cells via upregulating FAK
por: Zhou, Jian, et al.
Publicado: (2019)

Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signaling
por: Zhang, P-F, et al.
Publicado: (2016)

Tspan9 Induces EMT and Promotes Osteosarcoma Metastasis via Activating FAK-Ras-ERK1/2 Pathway
por: Shao, Shijie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_un5nrthqo3cp2e3bmdij12qa7m